,5 This overlap, rather than diminishing the utility of SAAs, underscores the clinical relevance of detecting α-synuclein seeding in non-synucleinopathies, influencing disease progression and phenotypic expression.6 This evidence concerns the gene PCSK1N and synucleinopathy.